Cost Effectiveness of TNF-𝛼 Inhibitors in Rheumatoid Arthritis

Figure 2

Illustration of the DAS-28 scores reported by every patient at baseline (prior to initiation of TNF-𝛼 inhibitor therapy) and at phase 3 (6 months after initiation of TNF-𝛼 inhibitor therapy).